{"id":"https://openalex.org/W2891996609","doi":"https://doi.org/10.1158/1541-7786.mcr-18-0327","title":"Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma","display_name":"Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma","publication_year":2018,"publication_date":"2018-09-10","ids":{"openalex":"https://openalex.org/W2891996609","doi":"https://doi.org/10.1158/1541-7786.mcr-18-0327","mag":"2891996609","pmid":"https://pubmed.ncbi.nlm.nih.gov/30201825"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.mcr-18-0327","doi":"https://doi.org/10.1158/1541-7786.mcr-18-0327","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-18-0327","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088831762","display_name":"Grace P. Leung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grace P. Leung","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080932337","display_name":"Tianshu Feng","orcid":"https://orcid.org/0000-0002-8798-0341","observed_orcids":["https://orcid.org/0000-0002-8798-0341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianshu Feng","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049448904","display_name":"Frederic D. Sigoillot","orcid":"https://orcid.org/0000-0002-8695-4838","observed_orcids":["https://orcid.org/0000-0002-8695-4838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederic D. Sigoillot","raw_affiliation_strings":["2Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103035323","display_name":"Felipe Correa Geyer","orcid":"https://orcid.org/0000-0002-9978-6650","observed_orcids":["https://orcid.org/0000-0002-9978-6650","https://orcid.org/0000-0002-9625-2346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felipe C. Geyer","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017572224","display_name":"Matthew D. Shirley","orcid":"https://orcid.org/0000-0003-0855-9274","observed_orcids":["https://orcid.org/0000-0003-0855-9274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew D. Shirley","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069634653","display_name":"David A. Ruddy","orcid":"https://orcid.org/0000-0001-8244-5609","observed_orcids":["https://orcid.org/0000-0001-8244-5609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Ruddy","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028677232","display_name":"Daniel P. Rakiec","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel P. Rakiec","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045089083","display_name":"Alyson K. Freeman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alyson K. Freeman","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040093136","display_name":"Jeffrey A. Engelman","orcid":"https://orcid.org/0009-0004-0775-4523","observed_orcids":["https://orcid.org/0009-0004-0775-4523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey A. Engelman","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088929965","display_name":"Mariela Jaskelioff","orcid":"https://orcid.org/0000-0002-5415-6401","observed_orcids":["https://orcid.org/0000-0002-5415-6401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariela Jaskelioff","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049772515","display_name":"Darrin D. Stuart","orcid":"https://orcid.org/0000-0002-4666-4000","observed_orcids":["https://orcid.org/0000-0002-4666-4000"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darrin D. Stuart","raw_affiliation_strings":["1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7951,"has_fulltext":false,"cited_by_count":73,"citation_normalized_percentile":{"value":0.86057085,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"1","first_page":"199","last_page":"211"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7649999856948853},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/raf-mek-erk-pathway","display_name":"Raf/MEK/ERK pathway","score":0.7089999914169312},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.925000011920929},{"id":"https://openalex.org/keywords/secreted-proteins","display_name":"secreted proteins","score":0.8009999990463257},{"id":"https://openalex.org/keywords/mek1","display_name":"MEK1","score":0.7039999961853027},{"id":"https://openalex.org/keywords/shrna-screen","display_name":"shRNA screen","score":0.671999990940094},{"id":"https://openalex.org/keywords/isogenic-cell-models","display_name":"isogenic cell models","score":0.47600001096725464},{"id":"https://openalex.org/keywords/xenograft-tumor-regression","display_name":"xenograft tumor regression","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C2778366672","wikidata":"https://www.wikidata.org/wiki/Q5957687","display_name":"Hyperactivation","level":2,"score":0.9101749658584595},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.8497697114944458},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6465201377868652},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5568159222602844},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5257059931755066},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.4683396518230438},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.4428630769252777},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4186716079711914},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.39549916982650757},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3825371563434601},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18240448832511902},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0712553858757019}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1541-7786.mcr-18-0327","doi":"https://doi.org/10.1158/1541-7786.mcr-18-0327","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-18-0327","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},{"id":"pmid:30201825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30201825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer research : MCR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306091","display_name":"American Association for Cancer Research","ror":"https://ror.org/02fnpv153"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1590910846","https://openalex.org/W1950829641","https://openalex.org/W1963909294","https://openalex.org/W1965909642","https://openalex.org/W1977800604","https://openalex.org/W1987191607","https://openalex.org/W1989594172","https://openalex.org/W1990376228","https://openalex.org/W2001591494","https://openalex.org/W2004295816","https://openalex.org/W2008757142","https://openalex.org/W2009642188","https://openalex.org/W2012650343","https://openalex.org/W2017187984","https://openalex.org/W2031541159","https://openalex.org/W2032211985","https://openalex.org/W2038683568","https://openalex.org/W2040286515","https://openalex.org/W2043058822","https://openalex.org/W2043398720","https://openalex.org/W2051165598","https://openalex.org/W2053473615","https://openalex.org/W2055380229","https://openalex.org/W2058390096","https://openalex.org/W2062023554","https://openalex.org/W2081990599","https://openalex.org/W2085933321","https://openalex.org/W2087298951","https://openalex.org/W2105660237","https://openalex.org/W2111645707","https://openalex.org/W2112934459","https://openalex.org/W2123106337","https://openalex.org/W2128542677","https://openalex.org/W2130410032","https://openalex.org/W2133465414","https://openalex.org/W2134471382","https://openalex.org/W2149662085","https://openalex.org/W2155461614","https://openalex.org/W2157144029","https://openalex.org/W2158217645","https://openalex.org/W2163188200","https://openalex.org/W2166262263","https://openalex.org/W2465367340","https://openalex.org/W2592339836","https://openalex.org/W2739511077","https://openalex.org/W2754364682","https://openalex.org/W2761796839"],"related_works":["https://openalex.org/W2885192271","https://openalex.org/W7169805443","https://openalex.org/W2000876153","https://openalex.org/W2289311855","https://openalex.org/W3097920809","https://openalex.org/W2081295565","https://openalex.org/W3135174747","https://openalex.org/W2049413545","https://openalex.org/W2787684716","https://openalex.org/W2330940668"],"abstract_inverted_index":{"Abstract":[0],"The":[1,192],"most":[2],"frequent":[3],"genetic":[4],"alterations":[5],"in":[6,12,16,29,81,116],"melanoma":[7,83,208],"are":[8,54],"gain-of-function":[9],"(GOF)":[10],"mutations":[11],"BRAF,":[13],"which":[14,43,104,136],"result":[15],"RAF\u2013MEK\u2013ERK":[17],"signaling":[18,99],"pathway":[19,66],"addiction.":[20],"Despite":[21],"therapeutic":[22,225],"success":[23],"of":[24,40,47,63,77,89,97,124,147,173,194,223],"RAF":[25],"and":[26,143,183],"MEK":[27],"inhibitors":[28],"treating":[30],"BRAFV600-mutant":[31],"tumors,":[32],"a":[33,129],"major":[34],"challenge":[35],"is":[36,67],"the":[37,48,64,170,221],"inevitable":[38],"emergence":[39],"drug":[41,58],"resistance,":[42],"often":[44,55],"involves":[45],"reactivation":[46],"MAPK":[49,65,79,98,108,125,174,218],"pathway.":[50],"Interestingly,":[51],"resistant":[52],"tumors":[53],"sensitive":[56,210],"to":[57,101,180,211,217],"withdrawal,":[59],"suggesting":[60],"that":[61,138,152],"hyperactivation":[62,80,175,219],"not":[68,205],"tolerated.":[69],"To":[70,121],"further":[71],"characterize":[72],"this":[73,92,212],"phenomenon,":[74],"isogenic":[75],"models":[76],"inducible":[78],"BRAFV600E":[82],"cells":[84],"were":[85,190,209],"generated":[86],"by":[87,107],"overexpression":[88,196],"ERK2.":[90],"Using":[91],"model":[93],"system,":[94],"supraphysiologic":[95],"levels":[96],"led":[100],"cell":[102,127,148],"death,":[103,128],"was":[105,114,134,158,197],"reversed":[106],"inhibition.":[109],"Furthermore,":[110],"complete":[111],"tumor":[112],"regression":[113],"observed":[115],"an":[117],"ERK2-overexpressing":[118],"xenograft":[119],"model.":[120],"identify":[122],"mediators":[123],"hyperactivation\u2013induced":[126],"large-scale":[130],"pooled":[131],"shRNA":[132],"screen":[133],"conducted,":[135],"revealed":[137],"only":[139],"shRNAs":[140],"against":[141],"BRAF":[142],"MAP2K1":[144],"rescued":[145],"loss":[146],"viability.":[149],"This":[150,215],"suggested":[151],"no":[153],"single":[154],"downstream":[155],"ERK2":[156,195],"effector":[157],"required,":[159],"consistent":[160],"with":[161],"pleiotropic":[162],"effects":[163],"on":[164],"multiple":[165],"cellular":[166],"stress":[167],"pathways.":[168],"Intriguingly,":[169],"detrimental":[171],"effect":[172,193],"could":[176],"be":[177],"partially":[178],"attributed":[179],"secreted":[181,188],"factors,":[182],"more":[184],"than":[185],"100":[186],"differentially":[187],"proteins":[189],"identified.":[191],"highly":[198],"context":[199],"dependent,":[200],"as":[201],"RAS/RAF":[202,206],"mutant":[203],"but":[204],"wild-type":[207],"perturbation.":[213],"Implications:":[214],"vulnerability":[216],"raises":[220],"possibility":[222],"novel":[224],"approaches":[226],"for":[227],"RAS/RAF-mutant":[228],"cancers.":[229]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-09-27T00:00:00"}